{
    "paper_id": "d43c9028fc460b667d7b8e54c16f0a85de6f3c4d",
    "metadata": {
        "title": "Association of Common Comorbidities with Osteonecrosis: A Nationwide Population!based Case!control Study",
        "authors": [
            {
                "first": "Alina",
                "middle": [],
                "last": "Dima",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Alma",
                "middle": [
                    "Becic"
                ],
                "last": "Pedersen",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Lars",
                "middle": [],
                "last": "Pedersen",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Cristian",
                "middle": [],
                "last": "Baicus",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Reimar",
                "middle": [],
                "last": "Wernich",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Thomsen",
                "middle": [],
                "last": "Authors",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Dima",
                "middle": [
                    "A"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Pedersen",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Aarhus University Hospital",
                    "location": {
                        "addrLine": "Olof Palmes Alle 43*45",
                        "postCode": "DK*8200",
                        "settlement": "Aarhus N",
                        "country": "Denmark"
                    }
                },
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Baicus",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Aarhus University Hospital",
                    "location": {
                        "addrLine": "Olof Palmes Alle 43*45",
                        "postCode": "DK*8200",
                        "settlement": "Aarhus N",
                        "country": "Denmark"
                    }
                },
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Thomsen Rw",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Aarhus University Hospital",
                    "location": {
                        "addrLine": "Olof Palmes Alle 43*45",
                        "postCode": "DK*8200",
                        "settlement": "Aarhus N",
                        "country": "Denmark"
                    }
                },
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "Objective To examine recent time trends in the incidence of osteonecrosis in Denmark and to investigate different common comorbidities association with osteonecrosis in a population* based setting.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Ethics approval As this study did not involve any contact with patients or any intervention, according to Danish law it was not necessary to obtain permission from the Danish Scientific Ethical Committee.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Data sharing statement There are no additional unpublished data from this study.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Funding No specific grant from any public agency, commercial or not*for*profit sectors was received for the presented research. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "\u25ba Large size study within the setting of a healthcare registry system that grants complete and uniform data collecting.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Strengths and limitations of this study"
        },
        {
            "text": "\u25ba Case*control design (10 subjects for each case randomly selected on the index date); matched by sex, age, ethnicity, and geographical region diminishing the risk of selection bias.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Strengths and limitations of this study"
        },
        {
            "text": "\u25ba ICD*10 codes do not properly capture the jaw osteonecrosis. However, only a minority of jaw osteonecrosis appears to be clasified with similar codes.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Strengths and limitations of this study"
        },
        {
            "text": "\u25ba Information on important confounders were lacking (lifestyle factors or medication).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Strengths and limitations of this study"
        },
        {
            "text": "Nonetheless, we were able to mutually adjust as surrogate measure using the Charlson Comorbidity Index. while other authors indicated more than 15 ON cases per 100,000 inhabitants when evaluating total joint arthroplasties 1 . From Asia, a non*traumatic femoral ON incidence of 2.5 cases per 100,000 inhabitants has been reported in the Fukuoka Prefecture of Japan 6 .",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Strengths and limitations of this study"
        },
        {
            "text": "Among patients with cancer 7,8 , pulmonary diseases 5,9*11 , immunological conditions 8, 11, 12 , renal diseases 13 , or organ transplantation 8,14,15 corticosteroid therapy has been associated with increased risk of ON. Further, important lifestyle factors, including tobacco use 16, 17 and high alcohol consumption 16*18 may increase ON risk.",
            "cite_spans": [
                {
                    "start": 86,
                    "end": 88,
                    "text": "8,",
                    "ref_id": null
                },
                {
                    "start": 89,
                    "end": 92,
                    "text": "11,",
                    "ref_id": null
                },
                {
                    "start": 93,
                    "end": 95,
                    "text": "12",
                    "ref_id": null
                },
                {
                    "start": 281,
                    "end": 284,
                    "text": "16,",
                    "ref_id": null
                },
                {
                    "start": 285,
                    "end": 287,
                    "text": "17",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Strengths and limitations of this study"
        },
        {
            "text": "A few specific comorbid medical conditions have been associated with increased risk of ON 4,19*21 . The clinical implications of these findings may be limited, since many of the reported diseases, like sickle cell hemoglobinopathy, Gaucher disease, systemic lupus erythematosus, or caisson disease are relatively rare 19, 21 .",
            "cite_spans": [
                {
                    "start": 318,
                    "end": 321,
                    "text": "19,",
                    "ref_id": null
                },
                {
                    "start": 322,
                    "end": 324,
                    "text": "21",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Strengths and limitations of this study"
        },
        {
            "text": "In contrast, data are scarce about the impact of frequently occurring diseases in middle*aged and elderly populations on the risk of ON which may be of greater clinical and public health importance.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Strengths and limitations of this study"
        },
        {
            "text": "In order to fill the gap in current knowledge, we investigated recent time trends in the incidence of ON in Denmark, and examined the association between a number of common comorbidities included in the Charlson Comorbidity Index (CCI) and the risk of incident ON. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Strengths and limitations of this study"
        },
        {
            "text": "The study population consisted of all patients (cases) with a first ON diagnosis identified in the DNRP from 1995 through 2012. We used the following ICD*10 codes: idiopathic aseptic ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Study population"
        },
        {
            "text": "The Danish Civil Registry System was used to randomly select 10 population control subjects for each case on the date of first ON diagnosis (index date for controls). All control subjects were matched by age, sex, ethnicity (native vs. immigrants), and residency (same county). To be eligible for this study, subjects in the control group must also not have had a hospitalization with an ON diagnosis before the admission date for the corresponding ON case. In the present study, comorbidities were defined according to the CCI (see Appendix). Using ICD*10 codes as previously reported 23 , data on all comorbidities up to a 5*year period prior to the index date in cases and controls were obtained from the DNRP. The predictive positive value of these CCI comorbidities is documented high in the DNRP 23 . We also defined several severity levels of comorbidity, CCI low (with CCI score 0, thus having no recorded comorbidities), CCI mild (if CCI score 1), CCI moderate (if CCI score 2), or CCI severe (CCI score 3+).",
            "cite_spans": [
                {
                    "start": 586,
                    "end": 588,
                    "text": "23",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Selection of population controls"
        },
        {
            "text": "We estimated annual incidence rates of ON per 100,000 inhabitants as the number of new diagnosed ON cases occurring in entire Denmark per year divided by the number of residents January 1 st in the year of interest. Denominator data was available from Statistics Denmark 24 .",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Statistical analysis"
        },
        {
            "text": "We tabulated baseline characteristics of cases with first ON diagnosis and matched population control subjects. We then computed odds ratios (ORs) and 95% confidence intervals (CIs) for each comorbidity to proximate the relative risk of ON occurrence.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Statistical analysis"
        },
        {
            "text": "Adjusted odds ratios (aORs) were computed using multivariable logistic regression models, mutually adjusting for all other comorbidities than the one of interest. Due to the matched case*control design, all ORs were adjusted for age, sex, ethnicity, and place of residence too.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Statistical analysis"
        },
        {
            "text": "All analyses were performed using SAS statistical software (version 9.2; SAS Institute, Cary, NC, USA).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Statistical analysis"
        },
        {
            "text": "The overall mean annual incidence of ON in Denmark was 4.2 per 100,000 inhabitants for the period 1995*2012 (ranging between 3.3 and 5.9 per 100,000 inhabitants).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Incidence rates of osteonecrosis"
        },
        {
            "text": "As presented in Fig 1, 2.7%, respectively). The prevalence of all CCI diseases is listed in Table 2 . Table 2 summarizes also the association between each CCI disease category and the risk of ON. In matched unadjusted analyses, the moderate*severe liver disease ( 9.7, CI: 5.7 -16.5), lymphoma (OR = 7.3, CI: 5.6 -9.7), and leukemia (OR = 6.2, CI: 4.1 -9.6) categories were associated with the highest relative risk of incident ON. After mutually controlling for other than exposure comorbidities, the strength of these and most other associations decreased.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 16,
                    "end": 22,
                    "text": "Fig 1,",
                    "ref_id": null
                },
                {
                    "start": 92,
                    "end": 99,
                    "text": "Table 2",
                    "ref_id": "TABREF4"
                },
                {
                    "start": 102,
                    "end": 109,
                    "text": "Table 2",
                    "ref_id": "TABREF4"
                }
            ],
            "section": "Incidence rates of osteonecrosis"
        },
        {
            "text": "Solid cancer, the most common comorbidity in ON, was associated with an aOR of 2.0 (CI: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Previous studies found an estimated relative risk for ON development of 3.2 for occasional alcohol drinking 17 , 7.8 -13.1 for regular drinkers 16,17 and 17.9 in current drinkers with intake of greater than 1000 ml of alcohol weekly 16 . However, other factors than alcohol intake may play a role for increased ON risk in liver diseases 35 . ON occurrence seems to be lower in patients that present an immediate increase of cytolysis liver enzymes under steroid therapy, than in those without this quick response 36 . Furthermore, alcohol*related ON seems to be stronger associated with alcoholic liver disease than with alcoholic pancreatic disease 37 .",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 88,
                    "end": 313,
                    "text": "1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59",
                    "ref_id": "TABREF4"
                }
            ],
            "section": "Association of comorbidities with osteonecrosis"
        },
        {
            "text": "Also, other pathologies associated with bone impairment, including thrombocytopenia 8 , Our study has also several strengths, including its large size and a case*controlled design within the setting of a healthcare registry system that grants complete and uniform data collecting throughout entire Denmark. In order to control for confounding, we could match ON cases and controls by sex, age, ethnicity, and geographical region. Control patients were randomly selected from the Central Population Registry among the study base giving rise to ON cases, diminishing risk of selection bias. There is no recall bias in our case*control study because the data on comorbidity is based on information already prospective collected independently of our study goals. The comorbidities analyzed were coded prior the index date so it is less like to be ON sequels.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Association of comorbidities with osteonecrosis"
        },
        {
            "text": "In conclusion, this large population*based study provided evidence that the incidence of ON has increased over the last decade in Denmark. Common chronic conditions including cancer, chronic pulmonary disease, liver and renal disease, and diabetes are all associated with substantially increased risk of ON, and increases in the prevalence of these diseases in the population may also underlie the increasing ON trend observed. Ethics approval As this study did not involve any contact with patients or any intervention, according to Danish law it was not necessary to obtain permission from the Danish Scientific Ethical Committee.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Association of comorbidities with osteonecrosis"
        },
        {
            "text": "There are no additional unpublished data from this study.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data sharing statement"
        },
        {
            "text": "Funding No specific grant from any public agency, commercial or not*for*profit sectors was received for the presented research. 2.0 -2.7) for chronic pulmonary diseases. aORs were also increased at 2.8 (CI: 1.9 -4.1) and 4.5 (CI: 2.5 -8.2) for mild and moderate*to*severe liver disease, respectively, and 4.2 (CI:",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data sharing statement"
        },
        {
            "text": "3.4 -5.2) for renal disease.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data sharing statement"
        },
        {
            "text": "Conclusion This large population*based study provides evidence for an increasing osteonecrosis incidence in the general population and documents an association between several common comorbid conditions and risk of osteonecrosis. \u25ba ICD*10 codes did not allow for evaluating the type and location of osteonecrosis.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data sharing statement"
        },
        {
            "text": "\u25ba We lacked information on some confounders potentially associated with both comorbidity and osteonecrosis risk, including lifestyle factors and certain medications. In contrast, data are scarce about the impact of frequently occurring diseases in middle*aged and elderly populations on the risk of ON which may be of greater clinical and public health importance. In order to fill the gap in our current knowledge, we investigated recent time trends in the incidence of ON in Denmark, and examined the association between a number of common comorbidities included in the Charlson Comorbidity Index (CCI) and the risk of incident ON. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data sharing statement"
        },
        {
            "text": "The study population consisted of all patients (cases) with a first ON diagnosis identified in the DNRP from 1995 through 2012. We used the following ICD*10 codes: idiopathic aseptic ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Study population"
        },
        {
            "text": "The Danish Civil Registry System was used to randomly select 10 population control subjects for each case on the date of first ON diagnosis (index date for controls). All control subjects were matched by age, sex, ethnicity (native vs. immigrants), and residency (same county). To be eligible for this study, subjects in the control group were not allowed to have a hospitalization with an ON diagnosis before the admission date for the corresponding ON case. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Selection of population controls"
        },
        {
            "text": "In the present study, comorbidities were defined according to the CCI (see Appendix). Using ICD*10 codes as previously reported 23 , data on all comorbidities up to a 5*year period prior to the index date in cases and controls were obtained from the DNRP. The predictive positive value of these CCI comorbidities is documented high in the DNRP 23 . We also defined several severity levels of comorbidity, categorized as none (CCI score 0, thus having no recorded hospital*diagnosed comorbidities), mild comorbidity (CCI score 1 or 2), moderate comorbidity (CCI score 3 or 4), and severe comorbidity (CCI score 5+).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Comorbidities"
        },
        {
            "text": "We estimated annual incidence rates of ON per 100,000 inhabitants as the number of new diagnosed ON cases occurring in entire Denmark per year divided by the number of residents January 1 st in the year of interest. Denominator data was available from Statistics Denmark 24 .",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Statistical analysis"
        },
        {
            "text": "We tabulated baseline characteristics of cases with first ON diagnosis and matched population control subjects. We then computed odds ratios (ORs) and 95% confidence intervals (CIs) for each comorbidity to proximate the relative risk of ON occurrence.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Statistical analysis"
        },
        {
            "text": "Adjusted odds ratios (aORs) were computed using multivariable logistic regression models, mutually adjusting for all other comorbidities than the one of interest. Due to the matched case*control design, all ORs were adjusted for age, sex, ethnicity, and place of residence too.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Statistical analysis"
        },
        {
            "text": "All analyses were performed using SAS statistical software (version 9.2; SAS Institute, Cary, NC, USA).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Statistical analysis"
        },
        {
            "text": "The overall mean annual incidence of ON in Denmark was 4.2 per 100,000 inhabitants for the period 1995*2012 (ranging between 3.3 and 5.9 per 100,000 inhabitants). ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Incidence rates of osteonecrosis"
        },
        {
            "text": "We identified 4,107 patients with a first time ON*related hospitalization ( 2.7%, respectively). The prevalence of all CCI diseases is listed in Table 2 . Table 2 shows associations between each CCI disease category and the risk of ON. In matched unadjusted analyses, the moderate*to*severe liver disease ( 9.7, CI: 5.7 -16.5), lymphoma (OR = 7.3, CI: 5.6 -9.7), and leukemia (OR = 6.2, CI: 4.1 -9.6) categories were associated with the highest relative risk of incident ON. After mutually controlling for other than exposure comorbidities, the strength of these and most other associations decreased.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 145,
                    "end": 152,
                    "text": "Table 2",
                    "ref_id": "TABREF4"
                },
                {
                    "start": 155,
                    "end": 162,
                    "text": "Table 2",
                    "ref_id": "TABREF4"
                }
            ],
            "section": "Characteristics of patients with osteonecrosis"
        },
        {
            "text": "Solid cancer, the most common comorbidity in ON, was associated with an aOR of 2.0 (CI: 1.7 -2.2). For advanced metastatic cancers, leukemia, and lymphoma, aORs of ON were 3.4",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Association of comorbidities with osteonecrosis"
        },
        {
            "text": "(CI: 2.5 -4.5), 4.3 (CI: 2.7 -7.0), and 5.8 (CI: 4.3 -7.8), respectively. In addition, aORs were 2.8 (CI: 1.9 -4.1) and 4.5 (CI: 2.5 -8.2) for mild and moderate*to*severe liver disease, respectively, and also substantially increased at 4.2 (CI: 3.4 -5.2) for renal disease. Adjusted ON risk estimates were lowest for cardiovascular diseases such as myocardial infarction (aOR = 0.8, CI: 0.7 -1.1), congestive heart failure (aOR = 1.3, CI: 1.1 -1.6), peripheral vascular disease (aOR = 1.6, CI: 1.3 -1.9), and cerebrovascular disease (aOR = 1.2, CI: 1.0 -1.4), while the aOR for diabetes was 1.6 (CI: 1.4 -2.0).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Association of comorbidities with osteonecrosis"
        },
        {
            "text": "This large population*based study showed that the incidence of ON in Denmark was 4.2 per 100,000 during 1995*2012. ON incidence increased by 40% over 18 years, corroborating increasing time trends observed in other studies 2,25 .",
            "cite_spans": [],
            "ref_spans": [],
            "section": "DISCUSSION"
        },
        {
            "text": "Four out of ten patients with ON were burdened with major comorbid conditions before ON diagnosis, with malignancies, liver disease, and renal disease showing the strongest association with ON.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "DISCUSSION"
        },
        {
            "text": "The highest ON incidence was seen in 2011, at 5.9 per 100,000 inhabitants. The rising ON incidence over time may be related to an increasing use of corticosteroid therapy in the Danish population, although available data on overall corticosteroid use are scarce 26 , or may be related to the general longevity and increase in comorbidity burden observed in the general population 27 . Alternatively, the observed trends may reflect the use of more sensitive diagnostic tools, especially magnetic resonance imaging 2 .",
            "cite_spans": [],
            "ref_spans": [],
            "section": "DISCUSSION"
        },
        {
            "text": "Several factors, like radiotherapy and/ or chemotherapy may be involved in a causal relationship of malignancies with incident ON 7 . Bisphosphonates used e.g. in the management of multiple myeloma 28 and bone metastases 29 have been related to ON of the jaw 30 . For hematological cancers, hyperviscosity*induced leukostasis and leukemic infiltration have been suspected as underlying mechanisms 31 . Moreover, bone marrow transplantation is reportedly accompanied by a cumulative ON incidence after ten years of Our study also has several strengths, including its large size and a case*control design within the setting of a universally covering healthcare system that grants complete and uniform data collecting throughout entire Denmark. In order to control for confounding, we could match ON cases and controls by sex, age, ethnicity, and geographical region. Control subjects were randomly selected from the Central Population Registry among the study base giving rise to ON cases, diminishing risk of selection bias. There is no recall bias in our case* control study because the data on comorbidity is based on information already prospectively collected, independently of our study goals. The comorbidities analyzed were coded prior the index date and are thus unlikely to be ON sequels.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "DISCUSSION"
        },
        {
            "text": "In conclusion, this large population*based study provided evidence that the incidence of ON has increased over the last decade in Denmark. Common chronic conditions including cancer, chronic pulmonary disease, liver and renal disease, and diabetes are all associated with substantially increased risk of ON, and increases in the prevalence of these diseases in the population may also underlie the increasing ON trend observed. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 ",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 428,
                    "end": 657,
                    "text": "1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60",
                    "ref_id": "TABREF4"
                }
            ],
            "section": "DISCUSSION"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Mild (CCI score 1), n (%)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Moderate (CCI score 2), n (%)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Severe (CCI score 3+), n (%) 2,425 (59.0) 1997, n (%)",
            "authors": [],
            "year": 1998,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "CCI * Charlson Comorbidity Index, n * number Females, n (%)",
            "authors": [],
            "year": 1998,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "14--531997",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "CCI * Charlson Comorbidity Index, n * number Myocardial infarction, n (%)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Metastatic solid tumor, n (%) 102 (2.5)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF2": {
            "text": "incidence of osteonecrosis (ON), rare disorder with severe outcomes remains unknown in most countries and reported risk estimates vary substantially 1*4 . In Great Britain, annual ON incidences ranged from 1.4 to 3.0 per 100,000 inhabitants between 1989 and 2003 2 , while incidence rates lower than 1.0 per 100,000 inhabitants were reported in the Netherlands in 2003*2004 3 . For femoral ON, involving around 80% of all ON sites 2,5 , up to 6.3 episodes per 100,000 inhabitants have been predicted to occur in the United States 4 ;",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "*based case*control study was conducted in the entire Danish population (approximately 5.6 million inhabitants) 22 . The Danish National Health Service provides universal, tax*supported health care. The Danish National Registry of Patients (DNRP) holds information on all non*psychiatric hospital admissions since 1977 and hospital clinic outpatient visits since 1995. Each hospital contact is accompanied by up to 20 discharge diagnoses coded according to the International Classification of Diseases, 10th revision (ICD* 10), since 1994. Accurate linkage of all databases is possible by means of a unique ten digit personal number assigned to each Danish citizen and included in all medical and public registries.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "necrosis of the bone (M87.0), ON due to drugs (M87.1), ON due to previous trauma (M87.2), other secondary ON (M87.3), other ON (M87.8), and ON, unspecified (M87.9).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "107 osteonecrosis cases and 41,063 controls were included. The incidence of osteonecrosis increased from 3.9 in 1995 to 5.5 in 2012 per 100,000 inhabitants. Solid cancer was the most common comorbidity, associated with an aOR for osteonecrosis of 2.0: 1.7 -2.2. For advanced metastatic cancer, leukemia, and lymphoma, aORs of osteonecrosis were 3.4 (CI: 2.5 -4.5), 4.3 (CI: 2.7 -7.0), and 5.8 (CI: 4.3 -7.8), respectively. Among other chronic conditions, aORs were 3.5 (CI: 3.0 -4.1) for connective tissue diseases and 2.3 (CI:",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "necrosis of the bone (M87.0), ON due to drugs (M87.1), ON due to previous trauma (M87.2), other secondary ON (M87.3), other ON (M87.8), and ON, unspecified (M87.9).",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "a fluctuating ON incidence was observed especially for the first half of the study period, between 1995 and 2004. An upward trend was noted from 2005 likely to have previous diagnosis of most other conditions, including chronic pulmonary disease, connective tissue diseases, or diabetes (8.5% vs. 3.3%, 6.1 vs. 1.6%, and 5.9% vs.",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "ON incidence over time may be related to an increasing use of corticosteroid therapy, although available data on overall corticosteroid use are scarce 26 , or be due to the general longevity and increase in comorbidity burden observed in the general population 27 .Several factors, like radiotherapy and/ or chemotherapy may be involved in a causal relationship of malignancies with incident ON 7 . Bisphosphonates used e.g. in the",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "ContributorsABP defined the study idea. AD, ABP, LP, CB, and RWT conceived the paper. AD, CB, and RWT wrote the study protocol. LP extracted the data and led the statistical analysis. AllTable 1. Baseline characteristics of cases with first incident osteonecrosis and matched population control subjects. Denmark, 1995*2011 Odds ratios for the association of chronic conditions with incident osteonecrosis Fukushima W, Fujioka M, Kubo T, Tamakoshi A, Nagai M, Hirota Y. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. occupational status with the risk of idiopathic osteonecrosis of the femoral head. . 1993 Mar;137(5):530-8. 18. Fukushima W, Yamamoto T, Takahashi S, et al. The effect of alcohol intake and the use of oral corticosteroids on the risk of idiopathic osteonecrosis of the femoral head: a case* 19. Assouline*Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. . 2002 Oct;32(2):94-124. 20. Mont M, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten 21. Malizos KN, Karantanas AH, Varitimidis SE, Dailiana ZH, Bargiotas K, Maris T. 22. Schmidt M, Pedersen L, S\u00f8rensen HT. The Danish Civil Registration System as a tool in For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml 23. Thygesen SK, Christiansen CF, Christensen S, Lash TL, S\u00f8rensen HT. The predictive value of ICD*10 diagnostic coding used to assess Charlson comorbidity index conditions in the population*based Danish National Registry of Patients. 24. Statistics Denmark.2015; available at http://www.statbank.dk/HISB3. 25. Takahashi S, Fukushima W, Yamamoto T, et al. Temporal Trends in Characteristics of Newly Diagnosed Nontraumatic Osteonecrosis of the Femoral Head From 1997 to 2011: A 26. Davidsen JR, S\u00f8ndergaard J, Hallas J, Siersted HC, Lykkegaard J, Andersen M. Increased use of inhaled corticosteroids among young Danish adult asthmatics: an observational study. 27. Ording AG, S\u00f8rensen HT. Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs. . 2013 Jul;5:199-203. 28. Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma 29. Varun B, Sivakumar T, Nair BJ, Joseph AP. Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: A systematic review. 30. Ehrenstein V, Gammelager H, Schi\u00f8dt M, et al. Evaluation of an ICD*10 algorithm to detect osteonecrosis of the jaw among cancer patients in the Danish National Registry of Patients. 31. Moon JY, Kim BS, Yun HR, et al. A case of avascular necrosis of the femoral head as initial 32. Campbell S, Sun C*L, Kurian S, et al. Predictors of avascular necrosis of bone in long*term For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml 33. Lee J, Kwok SK, Jung SM, et al. Osteonecrosis of the hip in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. $ . 2014;23(1):39-45. 34. Fialho SCMS, Bonf\u00e1 E, Vitule LF, et al. Disease activity as a major risk factor for 36. Okazaki S, Nagoya S, Yamamoto M, et al. High risk of osteonecrosis of the femoral head in autoimmune disease patients showing no immediate increase in hepatic enzyme under 37. Chao Y*C, Wang S*J, Chu H*C, Chang W*K, Hsieh T*Y. Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. . 38(5):431-6. 38. Lim CY, Ong KO. Various musculoskeletal manifestations of chronic renal insufficiency. 39. Inoue S, Horii M, Asano T, et al. Risk factors for nontraumatic osteonecrosis of the femoral 40. Briggs WA, Hampers CL, Merrill JP, et al. Aseptic necrosis in the femur after renal 41. Miller KD, Masur H, Jones EC, et al. High prevalence of osteonecrosis of the femoral head in HIV*infected adults. . 2002 Jul;137(1):17-25. 42. Allison GT, Bostrom MP, Glesby MJ. Osteonecrosis in HIV disease: epidemiology, For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtmlFigure 1 Osteonecrosis annual incidence rates per 100,000 inhabitants, Denmark, 1995*2012For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml",
            "latex": null,
            "type": "table"
        },
        "TABREF5": {
            "text": "Odds ratios for the association of chronic conditions with incident osteonecrosis",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "Competing interest None of the authors received any fees, honoraria, grants or consultancies that would constitute a conflict of interest with the current study. AD benefited from a posdru scholarship, during the period of this project included. The Department of Clinical Epidemiology, Aarhus University Hospital, receives funding for other studies from companies in the form of research grants to (and administered by) Aarhus University; none of these studies has any relation to the present study.",
            "latex": null,
            "type": "table"
        },
        "TABREF7": {
            "text": "AbstractObjective To examine recent time trends in the incidence of osteonecrosis in Denmark and to investigate different common comorbidities association with osteonecrosis in a population* based setting.",
            "latex": null,
            "type": "table"
        },
        "TABREF8": {
            "text": "Strengths and limitations of this study\u25ba Large nationwide study within the setting of a universal healthcare system that grants complete and uniform health data collection.",
            "latex": null,
            "type": "table"
        },
        "TABREF9": {
            "text": ", renal diseases 13 , or organ transplantation8,14,15  corticosteroid therapy has been associated with increased risk of ON. Further, important lifestyle factors, including tobacco use 16,17 and high alcohol consumption 16*18 may increase ON risk. A few specific comorbid medical conditions have been associated with increased risk of ON 4,19*21 . The clinical implications of these findings may be limited, since many of the reported diseases, like sickle cell hemoglobinopathy, Gaucher disease, systemic lupus erythematosus, or caisson disease are relatively rare 19,21 .",
            "latex": null,
            "type": "table"
        },
        "TABREF13": {
            "text": "",
            "latex": null,
            "type": "table"
        },
        "TABREF15": {
            "text": "Table 1. Baseline characteristics of cases with first incident osteonecrosis and matched population control subjects. Denmark, 1995*2011 Odds ratios for the association of chronic conditions with incident osteonecrosis in Different Parts of the World. In: Osteonecrosis. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014. p. 35-7. 4. Lavernia CJ, Sierra RJ, Grieco FR. Osteonecrosis of the femoral head. Mont MA, Payman RK, Laporte DM, Petri M, Jones LC, Hungerford DS. Atraumatic osteonecrosis of the humeral head. J Rheumatol. 2000 Jul;27(7):1766-73. 6. Yamaguchi R, Yamamoto T, Motomura G, Ikemura S, Iwamoto Y. Incidence of nontraumatic osteonecrosis of the femoral head in the Japanese population. Shim K, MacKenzie MJ, Winquist E. Chemotherapy*associated osteonecrosis in cancer patients with solid tumours: a systematic review. . 2008;31(5):359-71. 8. Fukushima W, Fujioka M, Kubo T, Tamakoshi A, Nagai M, Hirota Y. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Colwell CW, Robinson CA, Stevenson DD, Vint VC, Morris BA. Osteonecrosis of the femoral head in patients with inflammatory arthritis or asthma receiving corticosteroid therapy. . 1996 Nov;19(11):941-6. 10. Griffith JF, Antonio GE, Kumta SM, et al. Osteonecrosis of Hip and Knee in Patients with Severe Acute Respiratory Syndrome Treated with Steroids. 11. Shigemura T, Nakamura J, Kishida S, et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. 12. Dima A, Pedersen AB, Pedersen L, Baicus C, Thomsen RW. Risk of osteonecrosis in patients with systemic lupus erythematosus: A nationwide population*based study For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml 14. Torii Y, Hasegawa Y, Kubo T, et al. Osteonecrosis of the femoral head after allogeneic bone 15. Fink JC, Leisenring WM, Sullivan KM, Sherrard DJ, Weiss NS. Avascular necrosis following bone marrow transplantation: a case*control study. . 1998 Jan;22(1):67-71. 16. Matsuo K, Hirohata T, Sugioka Y, Ikeda M, Fukuda A. Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoral head. 17. Hirota Y, Hirohata T, Fukuda K, et al. Association of alcohol intake, cigarette smoking, and occupational status with the risk of idiopathic osteonecrosis of the femoral head. . 1993 Mar;137(5):530-8. 18. Fukushima W, Yamamoto T, Takahashi S, et al. The effect of alcohol intake and the use of oral corticosteroids on the risk of idiopathic osteonecrosis of the femoral head: a case* 19. Assouline*Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. . 2002 Oct;32(2):94-124. 20. Mont M, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten 21. Malizos KN, Karantanas AH, Varitimidis SE, Dailiana ZH, Bargiotas K, Maris T. 22. Schmidt M, Pedersen L, S\u00f8rensen HT. The Danish Civil Registration System as a tool in For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml 23. Thygesen SK, Christiansen CF, Christensen S, Lash TL, S\u00f8rensen HT. The predictive value of ICD*10 diagnostic coding used to assess Charlson comorbidity index conditions in the population*based Danish National Registry of Patients. 24. Statistics Denmark.2015; available at http://www.statbank.dk/HISB3. 25. Takahashi S, Fukushima W, Yamamoto T, et al. Temporal Trends in Characteristics of Newly Diagnosed Nontraumatic Osteonecrosis of the Femoral Head From 1997 to 2011: A Hospital*Based Sentinel Monitoring System in Japan. 26. Davidsen JR, S\u00f8ndergaard J, Hallas J, Siersted HC, Lykkegaard J, Andersen M. Increased use of inhaled corticosteroids among young Danish adult asthmatics: an observational study. . 2010 Dec;104(12):1817-24. 27. Ording AG, S\u00f8rensen HT. Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs. . 2013 Jul;5:199-203. 28. Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors . 2006 Feb;24(6):945-52. 29. Varun B, Sivakumar T, Nair BJ, Joseph AP. Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: A systematic review. 30. Ehrenstein V, Gammelager H, Schi\u00f8dt M, et al. Evaluation of an ICD*10 algorithm to detect osteonecrosis of the jaw among cancer patients in the Danish National Registry of Patients. 31. Moon JY, Kim BS, Yun HR, et al. A case of avascular necrosis of the femoral head as initial presentation of chronic myelogenous leukemia. # 32. Campbell S, Sun C*L, Kurian S, et al. Predictors of avascular necrosis of bone in long*term For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml survivors of hematopoietic cell transplantation. . 2009 Sep;115(18):4127-35. 33. Lee J, Kwok SK, Jung SM, et al. Osteonecrosis of the hip in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. $ . 2014;23(1):39-45. 34. Fialho SCMS, Bonf\u00e1 E, Vitule LF, et al. Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus. $ . 2007;16(4):239-44. 35. Shibata A, Fukuda K, Inoue A, et al. Flushing pattern and idiopathic avascular necrosis of 36. Okazaki S, Nagoya S, Yamamoto M, et al. High risk of osteonecrosis of the femoral head in autoimmune disease patients showing no immediate increase in hepatic enzyme under 37. Chao Y*C, Wang S*J, Chu H*C, Chang W*K, Hsieh T*Y. Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. . 38(5):431-6. 38. Lim CY, Ong KO. Various musculoskeletal manifestations of chronic renal insufficiency. 39. Inoue S, Horii M, Asano T, et al. Risk factors for nontraumatic osteonecrosis of the femoral head after renal transplantation. . 2003 Nov;8(6):751-6. 40. Briggs WA, Hampers CL, Merrill JP, et al. Aseptic necrosis in the femur after renal 41. Miller KD, Masur H, Jones EC, et al. High prevalence of osteonecrosis of the femoral head in HIV*infected adults. . 2002 Jul;137(1):17-25. 42. Allison GT, Bostrom MP, Glesby MJ. Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. . 2003 Jan;17(1):1-9. For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml Table 1 Baseline characteristics of cases with first incident osteonecrosis and matched population control subjects. Denmark, 1995*2011 For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml",
            "latex": null,
            "type": "table"
        },
        "TABREF16": {
            "text": "Odds ratios for the association of chronic conditions with incident osteonecrosis For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtmlAppendix International Classification of Diseases, 10th revision codes used in the Charlson comorbidity Chronic pulmonary disease J40-J47; J60-J67; J68.4; J70.1; J70.3; J84.1; J92.0; J96.1; J98.2-J98.3 Connective tissue disease M05; M06; M08; M09; M30-M36; D86 1 Mild liver disease B18; K70.0-K70.3; K70.9; K71; K73; K74;Moderate to severe renal disease I12; I13; N00-N05; N07; N11; N14; N17-HIV/AIDS -Human immunodeficiency virus infection and acquired immune deficiency syndromeFor peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}